September 2017

Published Time:

2017-09-30

Author:

Source:


Abstract

Established the CAS Shenzhen Institute of Advanced Technology Realbio Yang City Biotechnology Joint Laboratory in collaboration with the Chinese Academy of Sciences;
Awarded the Yangcheng County Science and Technology Innovation Advanced Collective;
Passed the ISO9001 quality system certification of the International Organization for Standardization;
Awarded the global Best Newcome certificate by Randox;
Realbio trademark successfully registered, establishing the brand;
Passed the Randox non-medical device risk assessment, achieving the large-scale import of Class B risk products for the first time

Established the joint laboratory of the Chinese Academy of Sciences Shenzhen Institute of Advanced Technology and Realbio Yangcheng Biotechnology; 
Awarded the Yangcheng County Science and Technology Innovation Advanced Collective; 
Passed the ISO9001 quality system certification of the International Organization for Standardization; 
Awarded the global Best Newcome certificate by UK Randox; 
Realbio trademark successfully registered, establishing the brand; 
Passed the Randox non-medical device risk assessment, achieving the first large-scale import of Class B risk products

Keywords:

IVD Raw Materials | Biological Products

HOT NEWS


ADLM 2026 | Connecting Global IVD Innovation, Exploring New Paradigms in IVD


As one of the most influential industry events in the field of laboratory medicine worldwide, ADLM 2026 (Association for Diagnostics & Laboratory Medicine) will be held from July 26–30, 2026, in Anaheim, California, USA. It is expected to bring together diagnostic companies, research institutions, clinical laboratories, and industry chain partners from over 100 countries to showcase the latest technologies and innovative achievements in laboratory medicine and in vitro diagnostics. Each year, ADLM attracts hundreds of exhibiting companies and covers a broad spectrum of areas including molecular diagnostics, immunoassays, clinical chemistry, POCT, mass spectrometry, and digital laboratories, making it a vital exchange platform for the global IVD industry.

2026-07-14

Realbio and Thermo Fisher have entered into a strategic partnership to co-build a new ecosystem for localized IVD quality control services.


On May 12, the strategic signing ceremony between Realbio and Thermo Fisher Scientific, a global leader in scientific services, was successfully held at the Thermo Fisher Customer Experience Center in Shanghai. The two parties will engage in in-depth collaboration on "integrated solutions for in-vitro diagnostic quality control materials," jointly embarking on a new chapter of resource sharing and value co-creation. Attendees at the signing ceremony included Patrick Jones, Global President of Professional Diagnostics at Thermo Fisher; Anuj Dhingra, Global Vice President of Professional Diagnostics; Linda Tang, Commercial Director of Professional Diagnostics, China; Luca Saronni, Global Chief Business Development Manager of Clinical Diagnostics; Liangchao Huang, Senior Sales Manager of Clinical Diagnostics, China; Anita Zhang, Product Specialist of Clinical Diagnostics Marketing, China; as well as Su Shaobo, Chairman of Shenzhen Realbio Group; Jiang Wenyu, Deputy General Manager of Operations; and Ji Hongyu, International Business Development Manager. This signing represents not only a joining of hands between the two enterprises but also another significant milestone for Ruiyali in enhancing its local industrial translation capabilities.

2026-05-12

Guangdong Provincial Engineering Technology Research Center for IVD Core Raw Materials (Realbio) Inauguration & Cooperation Signing Ceremony between Shenzhen Realbio Group and Shenzhen CDC


On April 9, Realbio Group and the Shenzhen CDC officially signed a strategic cooperation agreement in Shenzhen. The two parties will engage in in-depth collaboration on the construction of a clinical translation evaluation system for in-vitro diagnostics (IVD), with the aim of bridging the "last mile" from the laboratory to clinical application, enhancing the industry's regulatory market access capabilities, and contributing to the development of a public service platform for the diagnostics field in the Greater Bay Area.

2026-04-10

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News
  • Introduction
  • Corporate Outlets
  • FAQ
  • Corporate Video
  • Corporate Brochure